Global Top 4 Companies Accounted for 52% of total Oral Proteins and Peptides market (Business Opportunities - Advertising Service)

CANetAds > Business Opportunities > Advertising Service

Item ID 3871829 in Category: Business Opportunities - Advertising Service

Global Top 4 Companies Accounted for 52% of total Oral Proteins and Peptides market


Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids together with a peptide chain, and it is also an intermediate product of proteolysis. N polypeptide chains are entangled in a certain spatial structure to form a protein. The hydrolysis of macromolecular proteins produces polypeptides. Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.
The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.
Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
The global key manufacturers of Oral Proteins and Peptides include Ironwood & Allergan (AbbVie), Novartis, etc. In 2021, the global top three players had a share approximately 52.0% in terms of revenue.

For more information, please contact the following e-mail address:
Email: global@qyresearch.com
Website: https://www.qyresearch.com



Target Prov.: All Provinces
Target City : All Cities
Last Update : May 13, 2024 3:18 AM
Number of Views: 20
Item  Owner  : Laura
Contact Email: (None)
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
CANetAds > Business Opportunities > Advertising Service
 © 2024 CANetAds.com
2024-06-01 (0.547 sec)